While results in experimental models are promising, research remains preliminary, and findings are not yet conclusive for translational outcomes
IGFBP-3 is one of the most clinically insightful yet underutilized markers in functional medicine
CJC-1295 is a GHRH analog, while Ipamorelin is commonly described as a growth hormone secretagogue that acts through ghrelin-related signaling
Active or recent malignancy is treated as a hard contraindication in the clinical literature, and a history of hormone-sensitive cancer warrants specialist input
Studies demonstrate IGF-1 DES improves social interaction, novel-object recognition, contextual fear conditioning, and reduces repetitive behaviors in autism models
Semaglutide for managing overweight and obesity (TA875)